NO178134C - Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse - Google Patents

Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse

Info

Publication number
NO178134C
NO178134C NO873273A NO873273A NO178134C NO 178134 C NO178134 C NO 178134C NO 873273 A NO873273 A NO 873273A NO 873273 A NO873273 A NO 873273A NO 178134 C NO178134 C NO 178134C
Authority
NO
Norway
Prior art keywords
preparation
tablet
prolonged release
formulation adjuvant
sustained
Prior art date
Application number
NO873273A
Other languages
English (en)
Norwegian (no)
Other versions
NO178134B (no
NO873273D0 (no
NO873273L (no
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO873273D0 publication Critical patent/NO873273D0/no
Publication of NO873273L publication Critical patent/NO873273L/no
Publication of NO178134B publication Critical patent/NO178134B/no
Publication of NO178134C publication Critical patent/NO178134C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Vending Machines For Individual Products (AREA)
  • Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO873273A 1986-08-06 1987-08-05 Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse NO178134C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61183414A JPH0780754B2 (ja) 1986-08-06 1986-08-06 多顆粒型持続性錠剤

Publications (4)

Publication Number Publication Date
NO873273D0 NO873273D0 (no) 1987-08-05
NO873273L NO873273L (no) 1988-02-08
NO178134B NO178134B (no) 1995-10-23
NO178134C true NO178134C (no) 1996-01-31

Family

ID=16135361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873273A NO178134C (no) 1986-08-06 1987-08-05 Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse

Country Status (11)

Country Link
EP (1) EP0255725B1 (de)
JP (1) JPH0780754B2 (de)
KR (1) KR950002148B1 (de)
AT (1) ATE102480T1 (de)
CA (1) CA1315680C (de)
DE (1) DE3789258T2 (de)
DK (1) DK175798B1 (de)
ES (1) ES2050653T3 (de)
FI (1) FI96480C (de)
NO (1) NO178134C (de)
PH (1) PH25545A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
WO1995010264A1 (en) * 1993-10-12 1995-04-20 Tokyo Tanabe Company Limited Tablet containing enteric granules
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
JP2004531467A (ja) 2000-11-28 2004-10-14 エフ　エム　シー　コーポレーション 可食性ｐｇａ被覆組成物
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
ES2351249T3 (es) 2001-07-27 2011-02-02 Astellas Pharma Inc. Composición que comprende partículas finas, de liberación sostenida, para comprimidos de disgregación rápida en la cavidad bucal.
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
JPS5873359A (ja) * 1981-10-27 1983-05-02 旭化成株式会社 医薬錠剤の製造方法

Also Published As

Publication number Publication date
FI96480B (fi) 1996-03-29
ES2050653T3 (es) 1994-06-01
DK175798B1 (da) 2005-02-28
CA1315680C (en) 1993-04-06
EP0255725A2 (de) 1988-02-10
NO178134B (no) 1995-10-23
PH25545A (en) 1991-08-08
DK407287A (da) 1988-02-07
FI96480C (fi) 1996-07-10
FI873407L (fi) 1988-02-07
JPS6339811A (ja) 1988-02-20
EP0255725A3 (de) 1991-01-30
JPH0780754B2 (ja) 1995-08-30
DE3789258T2 (de) 1994-08-11
KR950002148B1 (ko) 1995-03-14
FI873407A0 (fi) 1987-08-05
DK407287D0 (da) 1987-08-05
EP0255725B1 (de) 1994-03-09
DE3789258D1 (de) 1994-04-14
ATE102480T1 (de) 1994-03-15
NO873273D0 (no) 1987-08-05
NO873273L (no) 1988-02-08
KR880002510A (ko) 1988-05-09

Similar Documents

Publication Publication Date Title
NO884947D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk doseringsform med kontrollert frigjoerelse.
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
SE8504720D0 (sv) New drug preparation
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO178134C (no) Fremgangsmåte for fremstilling av en flergranultablett med langvarig avgivelse
FI945621A0 (fi) Säädetysti vapauttava valmiste
DE3776982D1 (de) Arzneimittel mit gesteuerter absorption.
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO167287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.
JPS6463521A (en) Trapidyl-containing drug composition, manufacture and related therapeutical use
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
GB1379008A (en) Medicament for the treatment of herpes simplex
AU2366388A (en) A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.
NO873805L (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JK THORSENS PATENTBUREAU AS, POSTBOKS 9276 GRONLAN

MK1K Patent expired